Our data strongly parallel the subclinical epileptiform activity in AD patients observed in preclinical APOE4 carriers51,52 and early stages of AD53, as well as its predominance during NREM sleep and its association with sleep disruptions60,61. The gene discussed is APOE; the disease is Alzheimer disease.